Myoclonic Epilepsy Latest Advances

Development of Novel Small-Molecule Targeting SCN1A-Associated Severe Myoclonic Epilepsy of Infancy.

Journal: Journal of medicinal chemistry

Published: January 23, 2026

Efficacy of Dravet Syndrome Treatments in a Subset of Individuals with 2q24.3 Deletion: A-5 Patient Case Series.

Journal: Journal of child neurology

Published: January 21, 2026

A Comparative Study of Clinical and Electroencephalographic Findings of the Children with Epilepsy with or without Cerebral palsy in a Tertiary Health Facility in Nigeria.

Journal: Nigerian medical journal : journal of the Nigeria Medical Association

Published: December 31, 2025

Dravet Syndrome Patient-Derived Neural Cells Present Altered Levels of Potassium, Copper, and Zinc.

Journal: ACS chemical neuroscience

Published: December 25, 2025

Infantile-Onset Unverricht-Lundborg Disease: A Unique Case With Severe Neurological Impairment and Positive Family History.

Journal: Journal of investigative medicine high impact case reports

Published: December 23, 2025

Fenfluramine for seizures associated with Dravet syndrome and Lennox-Gastaut syndrome.

Journal: Australian prescriber

Published: December 19, 2025

Clinical Reasoning: A 5-year-Old Boy With Subacute and Refractory Myoclonus.

Journal: Neurology

Published: December 03, 2025

Relieving the Weight: Fenfluramine's Re-emergence as Antiseizure Medication for Lennox-Gastaut and Dravet Syndrome.

Journal: The Annals of pharmacotherapy

Published: December 01, 2025

Epilepsy-associated Variants of a Single SCN1A Codon exhibit Divergent Functional Properties.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Correction to "Metabolomic signature of the Dravet syndrome: A genetic mouse model study".

Journal: Epilepsia

Published: November 21, 2025

ERBB4 colocalizes with phosphorylated tau aggregates in multiple tauopathies.

Journal: Neurochemistry international

Published: November 21, 2025

Intravenous immunoglobulin and febrile status epilepticus in children with Dravet syndrome: A retrospective multicentre study.

Journal: Developmental medicine and child neurology

Published: November 18, 2025

Myoclonic Epilepsy Latest Advances

Find the Latest Research About Myoclonic Epilepsy

Development of Novel Small-Molecule Targeting SCN1A-Associated Severe Myoclonic Epilepsy of Infancy.

Development of Novel Small-Molecule Targeting SCN1A-Associated Severe Myoclonic Epilepsy of Infancy.

Efficacy of Dravet Syndrome Treatments in a Subset of Individuals with 2q24.3 Deletion: A-5 Patient Case Series.

Efficacy of Dravet Syndrome Treatments in a Subset of Individuals with 2q24.3 Deletion: A-5 Patient Case Series.

A Comparative Study of Clinical and Electroencephalographic Findings of the Children with Epilepsy with or without Cerebral palsy in a Tertiary Health Facility in Nigeria.

A Comparative Study of Clinical and Electroencephalographic Findings of the Children with Epilepsy with or without Cerebral palsy in a Tertiary Health Facility in Nigeria.

Dravet Syndrome Patient-Derived Neural Cells Present Altered Levels of Potassium, Copper, and Zinc.

Dravet Syndrome Patient-Derived Neural Cells Present Altered Levels of Potassium, Copper, and Zinc.

Infantile-Onset Unverricht-Lundborg Disease: A Unique Case With Severe Neurological Impairment and Positive Family History.

Infantile-Onset Unverricht-Lundborg Disease: A Unique Case With Severe Neurological Impairment and Positive Family History.

Fenfluramine for seizures associated with Dravet syndrome and Lennox-Gastaut syndrome.

Fenfluramine for seizures associated with Dravet syndrome and Lennox-Gastaut syndrome.

Clinical Reasoning: A 5-year-Old Boy With Subacute and Refractory Myoclonus.

Clinical Reasoning: A 5-year-Old Boy With Subacute and Refractory Myoclonus.

Relieving the Weight: Fenfluramine's Re-emergence as Antiseizure Medication for Lennox-Gastaut and Dravet Syndrome.

Relieving the Weight: Fenfluramine's Re-emergence as Antiseizure Medication for Lennox-Gastaut and Dravet Syndrome.

Epilepsy-associated Variants of a Single SCN1A Codon exhibit Divergent Functional Properties.

Epilepsy-associated Variants of a Single SCN1A Codon exhibit Divergent Functional Properties.

Correction to "Metabolomic signature of the Dravet syndrome: A genetic mouse model study".

Correction to "Metabolomic signature of the Dravet syndrome: A genetic mouse model study".

ERBB4 colocalizes with phosphorylated tau aggregates in multiple tauopathies.

ERBB4 colocalizes with phosphorylated tau aggregates in multiple tauopathies.

Intravenous immunoglobulin and febrile status epilepticus in children with Dravet syndrome: A retrospective multicentre study.

Intravenous immunoglobulin and febrile status epilepticus in children with Dravet syndrome: A retrospective multicentre study.